MedTrace Logo

Evaluation of Double Faced Transverse Preputial Onlay Island Flap for Hypospadias Repair in Pediatrics

NCT05144659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2021-12-17

No results posted yet for this study

Summary

Evaluation of double faced transverse preputial onlay island flap for hypospadias repair in pediatrics. The preputial onlay island flap technique has been popularized for hypospadias repair as a result of offering a consistent combination of excellent cosmetic results and acceptable complication rates. Like other techniques, urethrocutaneous fistulae continue to be the most common complications, in addition to other complications, and can be attributed to the affection of flaps vascularity. Some authors describe a technique that resolves some of these problems by combining the unique benefits of the double-faced preputial flaps.

This study aimed to evaluate double faced preputial onlay island flap technique for complication rate, outcomes for urinary stream, and cosmetic results.

Conditions

  • Hypospadias

Interventions

PROCEDURE

Double faced transverse preputial onlay island flap

A well-established one-stage repair of penile hypospadias called Double faced transverse preputial onlay island flap

PROCEDURE

Transverse inner preputial onlay island flap

A second well-established one-stage repair of penile hypospadias called Transverse inner preputial onlay island flap

Sponsors & Collaborators

  • dr. Muhammad Abdelhafez Mahmoud, MD

    lead OTHER

Principal Investigators

  • Khalid Abdelhaleem Hefney, MD · Pediatric Surgery Department, Al-Azhar University, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
14 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-04-30
Completion
2021-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144659 on ClinicalTrials.gov